Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Frei

Showing results (321-330 of 428) with videos related to

Pageof 43
Sort By:
Clinical Pharmacology and Therapeutics|June 1, 1975
Pharmacokinetics of actinoymcin D in patients with malignant melanomaM H Tattersall, J E Sodergren, S K Dengupta, et al.
Cancer|October 15, 1980
Successful treatment of metastatic sarcomas with cyclophosphamide, adriamycin, and DTIC (CAD)R H Blum, J M Corson, R E Wilson, et al.
Cancer Research|November 1, 1989
Influence of schedule on alkylating agent cytotoxicity in vitro and in vivoB A Teicher, S A Holden, J P Eder, et al.
Anticancer Research|July 23, 1998
Chemopreventive effects of dithiocarbamates on aflatoxin B1 metabolism and formation of AFB1 adducts with glutathioneU V Gopalaswamy, E Frei, N Frank, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|March 23, 2002
Evidence for tip velocity oscillations in dendritic solidificationJ C LaCombe, M B Koss, J E Frei, et al.
Cancer|December 1, 1977
Adriamycin plus alkylating agents in the treatment of metastatic breast cancerJ J Lokich, A T Skarin, R J Mayer, et al.
Seminars in Oncology|February 1, 1990
Preclinical studies relating to the use of thiotepa in the high-dose setting alone and in combinationB A Teicher, S A Holden, J P Eder, et al.
Cancer|April 1, 1977
Prognotic significance of pretreatment proliferative activity in adult acute leukemiaJ S Hart, S L George, E Frei, et al.
Cancer Genetics and Cytogenetics|January 1, 1988
Four patients with myelodysplastic syndrome with translocation (1;7)(p11;p11) including one patient with independent clones del(7)q22) [corrected] and t(1;7)(q21;q11)R Tantravahi, M A Shipp, T A Greeley, et al.
Cancer Research|December 1, 1985
Phenotypic heterogeneity in cultured human head and neck squamous cell carcinoma lines with low-level methotrexate resistanceA Rosowsky, J E Wright, C A Cucchi, et al.
Pageof 43

Showing results (321-330 of 428) with videos related to

Sort By:
Pageof 43
Clinical Pharmacology and Therapeutics|June 1, 1975
Pharmacokinetics of actinoymcin D in patients with malignant melanomaM H Tattersall, J E Sodergren, S K Dengupta, et al.
Cancer|October 15, 1980
Successful treatment of metastatic sarcomas with cyclophosphamide, adriamycin, and DTIC (CAD)R H Blum, J M Corson, R E Wilson, et al.
Cancer Research|November 1, 1989
Influence of schedule on alkylating agent cytotoxicity in vitro and in vivoB A Teicher, S A Holden, J P Eder, et al.
Anticancer Research|July 23, 1998
Chemopreventive effects of dithiocarbamates on aflatoxin B1 metabolism and formation of AFB1 adducts with glutathioneU V Gopalaswamy, E Frei, N Frank, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|March 23, 2002
Evidence for tip velocity oscillations in dendritic solidificationJ C LaCombe, M B Koss, J E Frei, et al.
Cancer|December 1, 1977
Adriamycin plus alkylating agents in the treatment of metastatic breast cancerJ J Lokich, A T Skarin, R J Mayer, et al.
Seminars in Oncology|February 1, 1990
Preclinical studies relating to the use of thiotepa in the high-dose setting alone and in combinationB A Teicher, S A Holden, J P Eder, et al.
Cancer|April 1, 1977
Prognotic significance of pretreatment proliferative activity in adult acute leukemiaJ S Hart, S L George, E Frei, et al.
Cancer Genetics and Cytogenetics|January 1, 1988
Four patients with myelodysplastic syndrome with translocation (1;7)(p11;p11) including one patient with independent clones del(7)q22) [corrected] and t(1;7)(q21;q11)R Tantravahi, M A Shipp, T A Greeley, et al.
Cancer Research|December 1, 1985
Phenotypic heterogeneity in cultured human head and neck squamous cell carcinoma lines with low-level methotrexate resistanceA Rosowsky, J E Wright, C A Cucchi, et al.
Pageof 43